Observational studyEuropean journal of hospital pharmacy : science and practice2022

Long-term effectiveness and pharmacokinetics of the infliximab biosimilar CT-P13 after switching from the originator during the treatment of inflammatory bowel disease.

Nerea Martín-Gutiérrez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.